BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Arrowhead Research Corporation 

1118 East Green Street

Pasadena  California  91106  U.S.A.
Phone: 626-792-5549 Fax: 626-792-5554


SEARCH JOBS



Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.


 Key Statistics


Email: info@arrowres.com
Ownership: Public

Web Site: Arrowhead Research Corporation
Employees:
Symbol: ARWR
 



Industry
Medical Device






 Company News
Arrowhead Research Corporation (ARWR) Issues Open Letter To Shareholders 10/9/2014 9:07:51 AM
Arrowhead Research Corporation (ARWR) To Present ARC-520 Phase 2a Data In Late-Breaking Session At American Association for Study of Liver Diseases Liver Meeting® 2014 10/8/2014 11:04:31 AM
Arrowhead Research Corporation (ARWR) To Present At 10th Annual Meeting Of The Oligonucleotide Therapeutics Society 10/7/2014 8:32:58 AM
Arrowhead Research Corporation (ARWR) Expands Management Team With Appointment Of Susan Boynton As Vice President Global Regulatory Affairs 9/30/2014 9:49:04 AM
Arrowhead Research Corporation (ARWR) To Present At Biocentury’s NewsMakers In The Biotech Industry Conference 9/22/2014 9:19:34 AM
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Third Quarter Financial Results And Provides Update On ARC-520 8/13/2014 7:54:49 AM
Arrowhead Research Corporation (ARWR) To Report Fiscal 2014 Third Quarter Financial Results 8/1/2014 9:05:20 AM
Arrowhead Research Corporation (ARWR) Announces New Clinical Candidate ARC-AAT For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 6/19/2014 10:21:38 AM
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014 10:52:31 AM
Arrowhead Research Corporation (ARWR) Set To Join Russell 3000 Index 6/16/2014 8:45:56 AM
12345678910...